Karolinska Development (Sweden) Today
| KDEV Stock | SEK 1.04 0.01 0.95% |
Performance0 of 100
| Odds Of DistressOver 71
|
Karolinska Development is selling for under 1.04 as of the 1st of February 2025; that is 0.95 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.04. Karolinska Development has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 5th of August 2024 and ending today, the 1st of February 2025. Click here to learn more.
Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 267.28 M outstanding shares. More on Karolinska Development AB
Moving together with Karolinska Stock
Moving against Karolinska Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Karolinska Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Karolinska Development's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Karolinska Development or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Asia | Yan Cheng |
| Business Concentration | Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Karolinska Development AB (KDEV) is traded on Stockholm Exchange in Sweden and employs 7 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 510.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Karolinska Development's market, we take the total number of its shares issued and multiply it by Karolinska Development's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Karolinska Development operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 267.28 M outstanding shares.
Karolinska Development AB has accumulated about 42.4 M in cash with 16.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Karolinska Development Probability Of Bankruptcy
Ownership AllocationKarolinska Development maintains a total of 267.28 Million outstanding shares. Karolinska Development AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Karolinska Ownership Details
Karolinska Development Risk Profiles
Although Karolinska Development's alpha and beta are two of the key measurements used to evaluate Karolinska Development's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.38 | |||
| Standard Deviation | 3.34 | |||
| Variance | 11.18 | |||
| Risk Adjusted Performance | (0.03) |
Karolinska Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Karolinska Development without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Karolinska Development Corporate Management
Elected by the shareholders, the Karolinska Development's board of directors comprises two types of representatives: Karolinska Development inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Karolinska. The board's role is to monitor Karolinska Development's management team and ensure that shareholders' interests are well served. Karolinska Development's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Karolinska Development's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Per Aniansson | Investment Director | Profile | |
| Eva Montgomerie | Head of Accounting | Profile | |
| Johan Dighed | Chief CEO | Profile | |
| Linda Spahiu | Investment Mang | Profile | |
| Hans Toll | Chief Officer | Profile | |
| Viktor MD | Chief Officer | Profile |
Additional Tools for Karolinska Stock Analysis
When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.